EMEA-001856-PIP02-16-M02
Key facts
Invented name |
Alpivab
|
Active substance |
Peramivir
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0257/2021
|
PIP number |
EMEA-001856-PIP02-16-M02
|
Pharmaceutical form(s) |
Concentrate for solution for infusion
|
Condition(s) / indication(s) |
Treatment of influenza
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
BioCryst Ireland Limited
Tel. +1 9194505809 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001856-PIP02-16-M02
|
Compliance opinion date |
17/12/2021
|
Compliance outcome |
positive
|